BRPI0601884A - pharmaceutical composition applicable to the treatment of peyronie disease and its method of obtaining - Google Patents
pharmaceutical composition applicable to the treatment of peyronie disease and its method of obtainingInfo
- Publication number
- BRPI0601884A BRPI0601884A BRPI0601884A BRPI0601884A BR PI0601884 A BRPI0601884 A BR PI0601884A BR PI0601884 A BRPI0601884 A BR PI0601884A BR PI0601884 A BRPI0601884 A BR PI0601884A
- Authority
- BR
- Brazil
- Prior art keywords
- pharmaceutical composition
- obtaining
- treatment
- composition applicable
- peyronie
- Prior art date
Links
- 208000004362 Penile Induration Diseases 0.000 title abstract 3
- 208000020758 Peyronie disease Diseases 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 108010003272 Hyaluronate lyase Proteins 0.000 abstract 1
- 102000001974 Hyaluronidases Human genes 0.000 abstract 1
- 229930003427 Vitamin E Natural products 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 1
- 229960002773 hyaluronidase Drugs 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 229940046009 vitamin E Drugs 0.000 abstract 1
- 235000019165 vitamin E Nutrition 0.000 abstract 1
- 239000011709 vitamin E Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"COMPOSIçãO FARMACêUTICA APLICáVEL NA TERAPêUTICA DA DOENçA DE PEYRONIE E RESPECTIVO PROCESSO DE OBTENçãO". A presente invenção refere-se a uma composição farmacêutica aplicável na terapêutica da doença de Peyronie e seu respectivo processo de obtenção. A composição compreende na sua formulação ficina e eventualmente, vitamina-E e/ou hialuronidase."PHARMACEUTICAL COMPOSITION APPLICABLE IN PEYRONIE'S DISEASE THERAPY AND ITS OBTAINING PROCESS". The present invention relates to a pharmaceutical composition applicable to the treatment of Peyronie's disease and its method for obtaining it. The composition comprises in its phycin formulation and optionally vitamin E and / or hyaluronidase.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0601884 BRPI0601884A (en) | 2006-05-08 | 2006-05-08 | pharmaceutical composition applicable to the treatment of peyronie disease and its method of obtaining |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BRPI0601884 BRPI0601884A (en) | 2006-05-08 | 2006-05-08 | pharmaceutical composition applicable to the treatment of peyronie disease and its method of obtaining |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0601884A true BRPI0601884A (en) | 2006-09-26 |
Family
ID=37001367
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0601884 BRPI0601884A (en) | 2006-05-08 | 2006-05-08 | pharmaceutical composition applicable to the treatment of peyronie disease and its method of obtaining |
Country Status (1)
| Country | Link |
|---|---|
| BR (1) | BRPI0601884A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8465413B2 (en) | 2010-11-25 | 2013-06-18 | Coloplast A/S | Method of treating Peyronie's disease |
-
2006
- 2006-05-08 BR BRPI0601884 patent/BRPI0601884A/en not_active Application Discontinuation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8465413B2 (en) | 2010-11-25 | 2013-06-18 | Coloplast A/S | Method of treating Peyronie's disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2526933E (en) | BRUTON TYROSINE KINASE INHIBITORS | |
| CR9949A (en) | 5-LIPOXYGENASE ACTIVATING PROTEIN INHIBITORS (FLAP) | |
| MA29795B1 (en) | INHIBITORS OF DIPEPTIDYL PEPTIDASE FOR THE TREATMENT OF DIABETES | |
| BRPI0412909A (en) | use of rnai inhibiting parp activity for the manufacture of a cancer medicine | |
| BRPI0821027B8 (en) | 4-(4-cyano-2-thioaryl)dihydropyrimidinones for the treatment and/or prevention of lung and cardiovascular system injuries, their preparation process and their use, and medicine | |
| NO20092527L (en) | Promotional products, method of manufacture and use thereof | |
| BRPI0114927B8 (en) | non-aqueous pharmaceutical gel composition for application to the skin, and use of a composition | |
| BRPI0609393B8 (en) | uses of an 11-deoxy-prostaglandin compound | |
| BR0314299A (en) | Pyrrolidone derivatives as mao-b inhibitors | |
| BR112012008518A2 (en) | heterocyclic derivative and pharmaceutical composition | |
| BR112012006283A2 (en) | stabilized adamts13 formulation, method for manufacturing a stabilized adamts13 formulation, kit, and methods for treating or preventing a disease and for treating or preventing a stroke | |
| BRPI0013010B8 (en) | aqueous formulation of moxifloxacin sodium chloride, process for its preparation and application of said formulation, as well as preparation for combining and applying an aqueous solution of moxifloxacin hydrochloride | |
| BRPI0817262A2 (en) | Biaryl sulphonamide derivatives, pharmaceutical compositions containing them, process for their manufacture, method and uses for the therapeutic and / or prophylactic treatment of diseases and uses in the preparation of medicaments. | |
| PE20110711A1 (en) | TREATMENT OF COGNITIVE DISORDERS WITH (R) -7-CHLORO-N- (QUINUCLIDIN-3-IL) BENZO [B] THIOPHENE-2-CARBOXAMIDE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | |
| BR112012015188A8 (en) | composition and method for the treatment and / or prevention of angiogenesis-related eye disease | |
| CY1115725T1 (en) | UNIONS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF BETA-AMYLOIDIC DISEASES AND CONCLUSIONS | |
| WO2008063768A3 (en) | Compositions and methods for treating metabolic diseases | |
| BRPI0517846A (en) | azaindolcarboxamides | |
| BRPI0416854B8 (en) | sterile aqueous suspension of ciclesonide suitable for nebulization, method for its preparation and use of said suspension, as well as pharmaceutical product | |
| WO2008071790A3 (en) | Novel compositions and uses thereof | |
| BR112015029897A2 (en) | solid composition for oral administration containing ibandronic acid or a pharmaceutically acceptable salt thereof and vitamin d and process for obtaining said composition | |
| BRPI0916885B8 (en) | pharmaceutical composition | |
| BRPI0508177A (en) | compound, process for the production of compound, pharmaceutical composition, use of compound method for treating a disease and combination product | |
| TW200745132A (en) | Novel, acyclically substituted furopyrimidine derivatives and use thereof | |
| BRPI0509477A (en) | sulfonamide compounds for the treatment of neurodegenerative disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
| B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired |